Cargando…
Using Mendelian randomization study to assess the renal effects of antihypertensive drugs
BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors and/or in combination with calcium channel blockers (CCBs) are generally recommended as the first-line antihypertensive therapy for people with hypertension and kidney dysfunction. Evidence from large randomized controlled trials comprehensi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995783/ https://www.ncbi.nlm.nih.gov/pubmed/33766008 http://dx.doi.org/10.1186/s12916-021-01951-4 |